Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.

J Transl Med · 2017 · PMC5446707 · PMID 28549432

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

2.68%; p = 0.003) and also showed a trend to an increment compared to α-GalCer treated mice (5.21 ± 0.28% vs. 3.69 ± 0.71%; p = 0.06) (Fig. 3 b).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.